Authors Instructions

Mexican Journal of Oncology (Gaceta Mexicana de Oncología) is the official scientific and academic publication of the Mexican Society of Oncology – SMeO. It is a high-quality scientific peer-reviewed journal, that communicates to health professionals the most relevant and up-to-date advances in research and education in order to offer cutting-edge multidisciplinary care to cancer patients.

Mexican Journal of Oncology (Gaceta Mexicana de Oncología) publishes quarterly in electronic format and open access (free to readers and authors), in addition to several supplements during the year. 

To this end, the journal will consider contributions in the following sections:
 

– Editorial (by editor´s invitation)
 
– Original article
 
– Review article
 
– Clinical case (only for the annual supplement)


 

PREPARATION AND SUBMISSION OF MANUSCRIPTS
 

Manuscripts must be uploaded in electronic form through the editorial system at http://publisher.gamo-smeo.permanyer.com where the corresponding author should first register as an author in the platform. Once this author has obtained a username and password, the documents should be uploaded following the instructions.

**To avoid duplications in the system, please refrain from creating a new request when resubmitting your modified files. You should continue using the same reference until your manuscript completes the editorial process.**
 

All articles must include, without exception, title, name, and surname(s) of each author (without titles or positions), affiliation, name and address of the correspondence author, the complete manuscript, tables, and figures.

All articles should include a first page with personal data, a manuscript file completely anonymous and the declarations of conflicts of interest, funding, and ethical disclosures.

The articles should include the frontal page:

– Title in English and Spanish
– Running title, of no more than 40 characters
– First name, initial of the second name (if applicable) and surname(s) of each author (without title or role). Add a hyphen if a second surname is included. Example: Antonio P. Morales; or Antonio Morales, or Antonio
P. Morales-Andrade.
– Affiliations will be referenced with consecutive numbers in superscript, after the name of the author. Example: Antonio P. Morales1; XXXX2; etc.
– The institutional departments in which they are assigned: Unit, Service, Department / Hospital / Faculty and University / City, Province, Country.
– Name and current address of the author responsible for correspondence.
– Acknowledgements: All acknowledgements and financing information must be included. This section must go on the front page so that the main document of the manuscript remains anonymous.

The submitted works must be accompanied by a letter signed by all authors of the paper, stating that it has not been published previously, nor is it simultaneously under consideration by another journal, confirming the absence of conflicts of interest, and, if accepted, they agree to transfer the copyright to this journal. Download the template here.

Texts must be submitted in Microsoft Word format. Manuscripts must be correctly written in Spanish or English. The text must be typed, double-spaced in Times New Roman or Arial font, 12 points, and with each section starting on a new page: first page, English and Spanish abstracts with their keywords, full manuscript, references, tables, and figures footnotes. The pages will be numbered consecutively, beginning with the first page, and the number will be placed on the top of every page.


The main manuscript file should be completely anonymous and include the Spanish and English abstracts, full text, references, tables, and figures footnotes. 

For more information about manuscript preparation, we suggest consulting the website of Uniform Requirements for Manuscripts Submitted to Biomedical Journals (www.icmje.org).

For further details: International Committee of Medical Journal Editors (http://www.icmje.org/recommendations/browse/manuscript-preparation/preparing-for-submission.html). 


Spanish abstract
According to the specifications per article type.

English abstract
According to the specifications per article type.

Introduction
It must include background information, approach to the problem and purpose of the study, all clearly worded and well supported by the bibliography reviewed.

Material and methods
The characteristics of the sample and the methods used, with relevant references, will be clearly marked so that reading of this chapter allows similar studies to be conducted by other researchers. The statistical methods used must be marked with their corresponding reference. The authors must detail in this section the ethical procedures followed, necessary for experiments with animals, patients, confidential data management, informed consent, etc. Moreover, that they have obtained the corresponding authorization by the ethics committee of their institution.

Results
The main findings of the study must be included and may be compared only with figures or graphics which are strictly necessary and are intended to extend the information contained in the text. Do not repeat information in the text and tables and/or figures.

Discussion
The results must be contrasted with the information reported in the literature, and with the objectives and hypotheses expressed in the work. Original articles must not include a Conclusion section.

Conclusions
In this section, authors must summarize the main conclusions of their study and the future recommended studies in case conclusions are preliminary. Conclusions should agree with the objectives of the study, and they should be directly originated from the reported results.  

Acknowledgments
This section will contain acknowledgments to individuals and institutions, as well as funding sources. This section belongs to the first page in order for the main text to remain anonymous.

References
These will be presented in accordance with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (International Committee of Biomedical Journal Editors). References will be marked with consecutive Arabic numerals, sorted in the order in which they first appear in the text. They will be referred to in the text, tables, and figure footnotes with the corresponding numbers. In quotations with multiple authors (more than six authors), only the first 6 authors of the work must be included, followed by et al., after the abbreviation of the name/s of the 6th author. In case of 6 or fewer authors, all 6 must be included in the quotation (https://www.nlm.nih.gov/bsd/uniform_requirements.html).
 

• Articles published in periodic journals must appear in the following format: Welt CK, Chan JL, Bullen J, Murphy R, Smith P, DePaoli AM, et al. Recombinant human leptin in hypothalamic Women with amenorrhea. N Engl J Med. 2004;351 (10):987-97.

• References to books must include the name of the publisher, as well as the city and country of publication, and the year of publication, in accordance with the following model: Aréchiga H, Somolinos J. Contribuciones Mexicanas a la medicina moderna. México, D.F.: Fondo de Cultura Económica; 1994.

• References to chapters in books must appear as follows: Pasternak RC, Braunwald E. Acute myocardial infarction; or: Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL, eds. Harrison’s Principles of Internal Medicine. 12.a ed. Nueva York: McGraw-Hill Inc.; 1994., pp. 1066-77.



Tables
They must be double-spaced and consecutively numbered in Arabic numbers, in the order quoted in the text, with the titles in the top and the meaning of abbreviations as well as explanatory footnotes. They must be included at the end of the manuscript, after the references section.

Figures or graphs
Figure footnotes must be written double-spaced. The footnote must contain the information needed to correctly interpret the figure without resorting to the text. The text must reference them in order. Qualities: The graphics, layouts and drawings must be generated in high-resolution graphics programs (JPG, TIFF, EPS, PowerPoint, and Illustrator). All iconography must be original. Where this is not the case, the source reference must be quoted, and the author must obtain prior permission of the relevant publisher. In the figures, data already written in the text will not be repeated. Photographs of objects must include a rule to calibrate the reference measurements. In microphotographs, the microscopic magnification or reference micron bar must appear. The patient’s name, face, data, or any other recognizable feature will not be shown in the figures. We suggest that authors add color illustrations which enrich the text. The cost of color illustrations will be covered by the corresponding author.


 

ETHICAL CONSIDERATIONS


 Ethical disclosures
With regard to potential conflicts of interest, individual right to privacy and data confidentiality, as well and human and animal rights, the journal adheres to the latest version of the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals (formerly the Uniform Requirements for Manuscripts) published by the International Committee of Medical Journal Editors, found at http://www.icmje.org. Copies will be required of informed consent forms in the case of studies in patients and clinical cases, and of the letter from the Independent Ethics Committee of the corresponding institution in the case of clinical and experimental studies.


Human procedures must comply with the ethical standards of the Helsinki Declaration of 1975 (World Medical Association Declaration of Helsinki) Ethical Principles for Medical Research involving human subjects. JAMA 2000, 284:3043-5. Also, with the agreements given by the Ministry of Health, published on January 26, 1982 and the Rules for Ethics and Research from the institution where the study originated. Animal studies should follow similar guidelines (Institute of Laboratory Animal Resources, National Research Council. Guide for the care and use of laboratory animals. Washington, DC. National Academy Press, 1996). Regarding the confidentiality of data, you should inform on how the anonymous status of the participants and the confidentiality of their information were protected. 

You can download the format by accessing the following link: http://www.permanyer.com/formulario-responsabilidades/

Funding
Authors must mention all organizations that funded their research in the Funding section, including grant numbers when appropriate.

Conflicts of interest
Authors must describe any financial or personal relationship with any other person or organization, which can cause a conflicts of interest regarding this article.


TYPES OF ARTICLES 


 Editorial
This section will be devoted to the analysis and consideration of the population’s health problems, the different preventive and therapeutic approaches, and the advances achieved in the field. The maximum length will be 5 pages (bibliography included), 3 figures or tables, and 5 references. A máximum of 5 coauthors will be allowed.

Original articles
The maximum length is 20 pages (including abstracts, tables, figure captions, and references), and the manuscript must include a title in both Spanish and English (maximum of 120 characters, including spaces), 50 references, 10 coauthors.

The manuscript should follow this structure:

– Structured abstract in Spanish (maximum 250 words) and keywords (up to 6). The abstract must include the following sections: a) Background; b) Objectives; c) Methods; d) Results; and e) Conclusions.

– Structured abstract in English, with the same format and content as the Spanish version, and keywords.

– Main text, consisting of the following sections: a) Introduction; b) Methods; c) Results; d) Discussion; and e) Conclusions.

– References.

– Tables (optional). A maximum of 4 tables is allowed; any additional tables must be included as supplementary material.

– Figure captions and figures (optional). A maximum of 4 figures is allowed; any additional figures must be included as supplementary material.


Articles focused on research methodology that comply with the following criteria will also be considered under this category:

– Randomized clinical trials

– Approval from the corresponding institutional or ethics committee

– Declaration of funding, if aplicable

– Registration in a clinical trials registry (e.g., www.clinicaltrials.gov)
 

Review articles
The maximum length is 25 pages (including abstracts, tables, figure captions, and references), and the manuscript must include a title in both Spanish and English (maximum of 120 characters, including spaces), 60 references, 10 coauthors.

The manuscript should follow this structure:

– Abstract in Spanish (maximum 200 words), without sections, and up to 6 keywords.

– Abstract in English, which must be a faithful translation of the Spanish version, and keywords.

– Main text.

– References.

– Tables (optional). A maximum of 6 tables is allowed; any additional tables must be included as supplementary material.

– Figure captions and figures (optional). A maximum of 6 figures is allowed; any additional figures must be included as supplementary material
 

Clinical case
Section dedicated to the publication of “interesting cases” with all the characteristics of the presentations we make of patients every morning, that is, the most important and necessary aspects to make known the problem of the patient or patients, taken from the clinical history.

They must have a Spanish and English abstract (maximum 100 words) without sections, the introduction, presentation of the case, discussion, illustrations, and bibliography. Maximum length of 5 pages (bibliography included), 6 figures and/or tables, 30 references and up to 10 coauthors.

Clinical cases will only be published in the annual supplement and will not be included in ordinary issues, unless instructed by the Editor-in-chief. The author must take this last point into account when submitting the manuscript.

To promote the transparency and quality of the research, the authors will be asked as an essential requirement to self-assess adherence to the relevant international guidelines according to the type of study:

– Clinical trials: CONSORT (http://www.consort-statement.org/). In addition, all trials must be registered in one of the international databases, and the corresponding registration number must always be indicated.

– Observational studies: STROBE (www.strobe-statement.org).

– Diagnostic tests: STARD (www.equator-network.org/reporting-guidelines/stard/)

– For other types of studies, consult the guidelines on the EQUATOR initiative (http://www.equator-network.org/).

– For systematic reviews and meta-analyses, the authors will be required to submit the self-adherence form according to the PRISMA statement: (http://www.prisma-statement.org/).


 

COPYRIGHT

All papers must be submitted with a letter, signed by every author stating that the article has not been published previously nor have they been sent simultaneously to another journal; that there is no conflicts of interest; and if accepted, the copyright will be transferred to Sociedad Mexicana de Oncología. All material accepted for publication in Mexican Journal of Oncology will be property of the journal. Therefore, either total or partial reproduction must be authorized by the journal.

The opinions contained in the article are responsibility of the authors.

No articles will be accepted for review if they are not prepared in accordance with the instructions for authors.


 

EDITORIAL PROCESS

The editorial process consists of 6 stages:

1. Reception of the manuscript (indeterminate, depending on whether the author meets the requirements): its objective is to verify that the manuscript complies with the specifications of these instructions for authors and that the submitted documentation is complete.

2. Initial editorial review (maximum 5 business days): its objective is to corroborate the relevance, timeliness, originality, and scientific contribution of the manuscript, as well as the methodological and statistical soundness of the study. At this time, it will be submitted to an electronic plagiarism detection system. Derived from this, a rejected opinion may be obtained, or it will be sent for review by peer researchers.

3. Review by peer researchers (maximum 30 business days): the opinion of at least two experts in the area in question will be obtained, who will evaluate the technical and methodological aspects of the investigation.

4. Editorial review (maximum 7 business days): its objective is to make a decision based on the opinion of peer reviewers. The opinion can be rejected, major changes, minor changes or accepted. In the case of major or minor changes, it will be submitted again for evaluation by the initial peer reviewers.

5. Final edition (6 weeks): its objective is the technical and linguistic edition (and translation), layout of galleys, DOI assignment, and correction by the author.

6. Advanced publication: All manuscripts will be published ahead of print on the journal’s website as soon as they complete the editing process, until they are incorporated into a final issue of the journal.


PRINT PROOFS (PDF) OF ACCEPTED ARTICLES 

The corresponding author will receive proofs of the article for revision and correction of terminology errors, or any other updates related to facts/figures. As the article will already have been edited according to the journal’s internal editorial guidelines, style corrections will not be accepted. The corresponding author will receive an email with the article in PDF format, on which they can leave their comments. Authors will need to have Adobe Reader (version 9, or a later version), downloadable for free). For other system requirements, please visit the Adobe website.

Alternatively, authors may list their corrections and submit them via email. Any major changes at this stage will be subject to the approval of the Editor. Authors should make sure to include all changes in a single email, as we cannot guarantee the inclusion of subsequent corrections.

The proof review is the responsibility of the author.


Relevant links: